Michele Brown was vaccinated – but had a suppressed immune system. Would better health advice have saved her?

The mother-of-two carefully shielded until the government said it was safe to see friends and family. She had no idea how her existing conditions could affect her

The feeling of relief was immense as 58-year-old Michele Brown returned home from the vaccine centre. Her husband, Terry, 61, had taken time off from his job as a supervisor at a heavy machinery factory to drive her to her second Covid-19 vaccination at a Gateshead community centre. In the car, Michele told her partner of 40 years that she felt like a weight had been lifted off her shoulders. “She said: ‘At least we’ve got that done,’” Terry remembers. “‘We’ll be OK.’”

It was 28 April 2021. Michele, who had rheumatoid arthritis, an underactive thyroid and diabetes, had spent the last year and a half shielding indoors, on government advice. She was careful. She had a Covid station set up on the breakfast counter: lateral flow tests, bottles of antibacterial gel and disposable face masks. When family came to visit, a mask-wearing Michele would banish them to the furthest corner of the living room. “We couldn’t kiss her,” remembers her daughter, Kim Brown, 41, who lives in Durham. “She would say: ‘You might have the coronies! I don’t want no coronies. You’re not giving me that crap.’”

Continue reading...

Moderna or Novavax after AstraZeneca jab confers high Covid immunity, study finds

Finding is good news for lower-income countries that have not yet completed their primary vaccination campaigns

Combining a first dose of the AstraZeneca Covid-19 vaccine with a second dose of either the Moderna or the Novavax jabs results in far higher levels of neutralising antibodies and T-cells compared with two doses of the AstraZeneca jab, a study has found.

The finding has important implications for lower-income countries that have not yet completed their primary vaccination campaigns, as it suggests you do not need access to mRNA vaccines – and therefore ultra-cold storage facilities – to trigger an extremely potent Covid-19 vaccine response.

Continue reading...

Viagra could be used to treat Alzheimer’s disease, study finds

US scientists say users of sildenafil – the generic name for Viagra – are 69% less likely to develop the form of dementia than non-users

Viagra could be a useful treatment against Alzheimer’s disease, according to a US study.

Alzheimer’s disease, the most common form of age-related dementia, affects hundreds of millions of people worldwide. Despite mounting numbers of cases, however, there is currently no effective treatment.

Continue reading...

Omicron: what do we know about the new Covid variant?

Scientists are racing to establish the variant’s transmissibility, effect on immune system and chance of hospitalisation or death

Three major issues will determine the magnitude of the impact of the new Omicron variant of the Covid virus will have on the nation and the rest of the planet. What is the transmissibility of this new Covid variant? How good is it at evading the antibodies and T-cells that make up a person’s immune defences? What are the chances it will trigger severe illness that could lead to the hospitalisation, and possibly death, of an infected person.

Scientists are struggling to find definitive answers to these critically important questions, although evidence already suggests Omicron has the potential to cause serious disruption. “The situation is very finely tuned and could go in many different directions,” says Prof Rowland Kao of Edinburgh University.

Continue reading...

‘Wall of secrecy’ in Pfizer contracts as company accused of profiteering

US company faces scrutiny over Covid profits after UK agrees to secrecy clause

Ministers have agreed a secrecy clause in any dispute with the drugs manufacturer Pfizer over Britain’s Covid vaccine supply. Large portions of the government’s contracts with the company over the supply of 189m vaccine doses have been redacted and any arbitration proceedings will be kept secret.

The revelation comes as Pfizer is accused by a former senior US health official of “war profiteering’’ during the pandemic. In a Channel 4 Dispatches investigation to be broadcast this week, Tom Frieden, who was director of the US Centers for Disease Control and Prevention under Barack Obama, said: “If you’re just focusing on maximising your profits and you’re a vaccine manufacturer … you are war profiteering.”

Continue reading...

Covid antiviral pill molnupiravir/Lagevrio set for UK at-home trials

People most vulnerable to Omicron would reportedly be offered experimental pill within 48 hours of testing positive

The first at-home treatment for Covid-19 could reportedly be offered to UK patients before Christmas as an attempt to protect the most vulnerable from the Omicron variant.

The Sunday Telegraph reported that Sajid Javid is set to launch a national pilot of the Molnupiravir antiviral pill, marketed as Lagevrio.

Continue reading...

UK’s progress on Covid now squandered, warns top scientist

Sir Jeremy Farrar, director of Wellcome Trust, suggests emergence of Omicron variant means pandemic is far from over

The emergence of the Omicron variant shows that the world is “closer to the start of the pandemic than the end”, one of Britain’s most senior scientific figures has warned, as he lamented a lack of political leadership over Covid.

Sir Jeremy Farrar, the director of the Wellcome Trust who stepped down as a government scientific adviser last month, said the progress in combatting Covid-19 since its emergence was “being squandered”.

Continue reading...

How probable is it Omicron Covid variant will take hold in UK?

Analysis: UK’s early vaccine deployment and use of different vaccines from South Africa mean it’s too soon to say

Omicron is causing consternation around the world, with the variant found to be behind an exponential rise in Covid cases in South Africa. Yet with just 42 cases confirmed in the UK so far, and most European countries seeing numbers in the double rather than triple figures, could this be a tentative sign the variant may fail to take hold outside southern Africa? The bottom line is, it is too soon to say.

One issue is that there are important differences that make it difficult to compare the situations in South Africa and beyond.

Continue reading...

Covid: scientists find possible trigger for AstraZeneca jab blood clots

Experts hope better understanding of rare side effect of vaccine could help ‘turn the tide’ on pandemic

Scientists believe they may have found the trigger behind the extremely rare blood clot complications stemming from the Oxford/AstraZeneca’s Covid vaccine.

According to a team of researchers from Cardiff and the US, the reaction can be traced to the way the adenovirus used by the vaccine to shuttle the coronavirus’s genetic material into cells binds with a specific protein in the blood, known as platelet factor 4 (PF4).

Continue reading...

Omicron variant found around world as more nations tighten travel rules

US among more than 50 nations bringing in stricter border controls as variant is identified in 24 countries

The Omicron variant of Covid-19 has been identified in new countries around the globe, including the US, west Africa, the Gulf and Asia, as American authorities indicated they would further tighten border controls over concerns that the new strain may be more transmissible.

Underscoring the fast spread of the variant, the National Institute for Communicable Diseases in South Africa – where Omicron was first detected – said it had now been found in five out of nine provinces, and accounted for 74% of the virus genomes sequenced in November.

Continue reading...

Covid-19 variants may not evolve to be less dangerous, says Neil Ferguson

Senior UK scientist says extent of threat posed by Omicron will not be clear until end of year

People should not assume that Covid will evolve to become a milder disease, a senior scientist has warned, adding that the threat posed by the Omicron coronavirus variant will not be clear until the end of December.

Prof Neil Ferguson, head of the disease outbreak analysis and modelling group at Imperial College London, told MPs on Wednesday that while evolution would drive Covid to spread more easily the virus might not become less dangerous.

Continue reading...

When did Omicron Covid variant arrive in UK and is it spreading?

Analysis: scientists are working full tilt to answer these vital questions that may give clues as to what is to come

As new cases of Omicron continue to emerge in the UK, scientists are working full tilt to answer two vital questions: when did the variant arrive and is it spreading?

While at first glance those queries may seem less important than those around vaccine effectiveness or disease severity, the answers may give important clues as to what is to come.

Continue reading...

Omicron Covid variant ‘present in Europe at least 10 days ago’

Two cases of new Covid variant found in Netherlands predate last week’s alert from South Africa

The Omicron variant of Covid-19 was present in Europe at least 10 days ago and already appears to be spreading in the Netherlands and elsewhere.

“We have found the Omicron coronavirus variant in two test samples that were taken on November 19 and 23,” the Dutch health ministry said in a statement on Tuesday. “It is not yet clear whether these people had also visited southern Africa,” the ministry added.

Continue reading...

How dangerous is the Omicron variant?

The Omicron variant of Covid has prompted governments around the world to reintroduce border restrictions, with Australia shutting the border to southern Africa and delaying the reopening date for international students and visa holders. The federal government has called for calm, describing the variant as ‘manageable’, but what do we actually know about it?


Laura Murphy-Oates speaks to medical editor Melissa Davey about what scientists have discovered so far about Omicron and our evolving approach to combating Covid variants

Read more:

Continue reading...

Travel firms scramble to rearrange holidays amid new Covid measures

Swiss skiing holidays in doubt as country joins Spain in tightening travel rules to contain Omicron variant

Tour operators are scrambling to rearrange Swiss skiing holidays after the country joined Spain in tightening travel restrictions amid rising concerns about the spread of the new Omicron Covid variant.

From Saturday night, Switzerland mandated 10 days of quarantine for all new arrivals, in effect wrecking skiing holidays in the Swiss Alps until further notice. Travel firms are also wrestling with Spain’s ban on non-vaccinated arrivals that will affect British holidaymakers from Wednesday 1 December.

Continue reading...

Early action against Omicron is imperative to avoid devastating consequences | Ewan Birney

Scientists have sprung into action to identify the new Covid variant. We don’t yet know if it is a major threat - but we should not take any chances

It was only a matter of time before a new Sars-CoV-2 variant of concern emerged, requiring an urgent global response. It would seem that the Omicron variant, identified by scientists across Africa, including the National Institute for Communicable Diseases (NICD), poses the next major threat in the course of the pandemic. Early evidence from their genomic surveillance suggests that this new variant is a serious cause for concern and it is imperative that we act fast in response to this new information.

The variant has also been detected in Botswana and Hong Kong, and will undoubtedly continue to arise in other territories in the coming days; travel-related cases have appeared in Belgium and Israel. Two cases of the new variant have been detected in the UK at the time of writing.

Continue reading...

Omicron’s full impact will be felt in countries where fewer are vaccinated

Analysis: the new coronavirus variant seems highly transmissible, but the big question is whether it causes severe disease. Either way, poorer nations will be hit hardest

In early August Gideon Schreiber and a team of virologists at the Weizmann Institute of Science in Israel began playing around with the spike protein of the Sars-CoV-2 virus – the protein that allows the virus to enter our cells – to see if they could predict future mutations that could yield dangerous new variants of Covid-19.

At the time, Schreiber noted with concern that there were a variety of ways in which the spike protein could evolve. If all of these mutations occurred at once, it could yield a variant that was both extremely transmissible and potentially capable of evading some of the body’s immune defences, blunting the efficacy of the vaccines.

Continue reading...

Omicron: everything you need to know about new Covid variant

Key questions answered about coronavirus variant first detected in southern Africa

The variant was initially referred to as B.1.1.529, but on Friday was designated as a variant of concern (VOC) by the World Health Organization because of its “concerning” mutations and because “preliminary evidence suggests an increased risk of reinfection with this variant”. The WHO system assigns such variants a Greek letter, to provide a non-stigmatising label that does not associate new variants with the location where they were first detected. The new variant has been called Omicron.

Continue reading...

BioNTech says it could tweak Covid vaccine in 100 days if needed

Company says it will know in two weeks whether current Pfizer jab is effective against Omicron variant

BioNTech says it could produce and ship an updated version of its vaccine within 100 days if the new Covid variant detected in southern Africa is found to evade existing immunity.

The German biotechnology company is already investigating whether the vaccine it developed with US drugmaker Pfizer works well against the variant, named Omicron, which has caused concern due to its high number of mutations and initial suggestions that it could be transmitting more quickly.

Continue reading...

Novavax expected to be approved as fourth Covid vaccine in UK

Trials show the protein-based jab causes fewer side-effects – and hundreds of British jobs depend on it

Pfizer, AstraZeneca, Moderna. Britons have become so accustomed to the three Covid vaccines available in the UK that most have forgotten about another jab, Novavax – even though the government has ordered 60m doses and hundreds of British jobs depend on it.

Late last month the US company, with a factory on Teesside primed to manufacture doses, submitted final data to UK regulators and a positive decision is anticipated within days or weeks. It will bring to an end what feels like a long wait compared with the speedy development and approval of the other jabs, including for those who took part in trials.

Continue reading...